Eng L F, Lee Y L, Williams K, Fukayama G, Gerstl B, Kies M
Adv Exp Med Biol. 1978;100:329-46. doi: 10.1007/978-1-4684-2514-7_24.
The rate of clearance of porcine myelin basic protein (MBP) from plasma of rabbits was determined following intravenous injection of 20 mg MBP. The MBP level in the plasma was measured by a 2-site immunoradiometric assay with specific antibody to guinea pig MBP produced in rabbits. Plasma MBP-antibody levels were determined by competitive binding radioimmune assay (RIA). Unsensitized and those sensitized with complete Freund's adjuvant (CFA), with porcine MBP in CFA, and with whole porcine spinal cord in CFA were studied. Unsensitized and CFA sensitized rabbits exhibited maximum MBP levels in the plasma within two minutes after injection with rapid decrease to undetectable levels in one hour. Thirty-nine of the unsensitized (control) rabbits exhibited normal, rapid clearance and no subsequent physical signs of EAE while one of the control rabbits exhibited a slightly retarded clearance rate. Histologic examination of autopsy tissues from the control group revealed that five rabbits showed lesions which could be attributed to Encephalitozoan cuniculi or Toxoplasma and one rabbit autopsied 65 days after clearance had minimal EAE lesions. Rabbits sensitized with MBP exhibited a retarded rate of clearance at the acute stage of EAE and following recovery. Rabbits sensitized with whole spinal cord in CFA also exhibited a retarded rate of MBP clearance. Anti (MBP) antibodies were detected in the plasma of all rabbits which exhibited a retarded rate of MBP clearance. Significant rates of retardation were not detected until approximately three weeks after sensitization with CFA-MBP or CFA-spinal cord. While MBP antibody levels in most animals were not detected by the immunodiffusion technique, antibodies were demonstrated by RIA. The 20 mg MBP given intravenously is probably in great antigen excess and conducive to the formation of soluble MBP-anti (MBP) complexes in the blood.
静脉注射20毫克猪髓鞘碱性蛋白(MBP)后,测定了兔血浆中猪MBP的清除率。血浆中的MBP水平通过双位点免疫放射分析测定,该分析使用兔体内产生的针对豚鼠MBP的特异性抗体。血浆MBP - 抗体水平通过竞争性结合放射免疫分析(RIA)测定。研究了未致敏的兔子以及用完全弗氏佐剂(CFA)致敏的兔子,包括用CFA中的猪MBP致敏的兔子和用CFA中的全猪脊髓致敏的兔子。未致敏和CFA致敏的兔子在注射后两分钟内血浆中MBP水平达到最高,一小时内迅速降至不可检测水平。39只未致敏(对照)兔子表现出正常、快速的清除率,且没有随后的实验性自身免疫性脑脊髓炎(EAE)体征,而一只对照兔子的清除率略有延迟。对照组尸检组织的组织学检查显示,5只兔子的病变可归因于兔脑炎微孢子虫或弓形虫,一只在清除后65天进行尸检的兔子有轻微的EAE病变。用MBP致敏的兔子在EAE急性期和恢复后清除率延迟。用CFA中的全脊髓致敏的兔子也表现出MBP清除率延迟。在所有MBP清除率延迟的兔子血浆中都检测到了抗(MBP)抗体。在用CFA - MBP或CFA - 脊髓致敏后约三周才检测到明显的延迟率。虽然大多数动物的MBP抗体水平通过免疫扩散技术未检测到,但通过RIA证明了抗体的存在。静脉注射的20毫克MBP可能处于极大的抗原过量状态,有利于在血液中形成可溶性MBP - 抗(MBP)复合物。